Loading

Short Communication Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.46439/cardiology.1.003

Risk of aerosol transmission of SARS-CoV-2 in cardiovascular care

  • 1Cardiology Centers of the Netherlands, Amsterdam, The Netherlands
  • 2Van der Waals-Zeeman Institute, Institute of Physics, University of Amsterdam, The Netherlands
+ Affiliations - Affiliations

Corresponding Author

G. Aernout Somsen, s.kirilov@oftalabs.com

Received Date: January 11, 2021

Accepted Date: February 12, 2021

Abstract

Introduction: Cardiovascular patients are at increased risk of complications due to COVID19. Beside nosocomial transmission, microdroplet aerosols can be responsible for viral (SARSCoV-2) transmission. These droplets are especially important for (cardiac) diagnostic- and therapeutic procedures as medical teams operate close to the patient.

Results: We measured the aerosol persistence in different locations, among which an outpatient cardiology clinic. Aerosol persistence times vary greatly with the ventilation of the specific building or room.

Conclusion: To prevent transmission by microdroplet aerosols, space ventilation is crucial and should be at least 10 air changes per hour.

Keywords

COVID19, SARS-CoV-2, Aerosol transmission, Cardiovascular, Airborne transmission 

Author Information X